• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
49,248.22 -970.95
(-1.93%)
Dow Jones
7,218.05 -126.58
(-1.72%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.42 -0.12
(-0.13%)
EUR-INR
102.53 -0.37
(-0.36%)
GBP-INR
123.02 -0.43
(-0.35%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
209.9837791
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FREDUN
54.63
2924.62
EPS(TTM)
Face Value()
Div & Yield %
31.26
10
0.01
 

hcl technologies ltd
Regent Enterprises reports standalone net loss of Rs 3.16 crore in the March 2026 quarter
May 23,2026
Net Loss of Regent Enterprises reported to Rs 3.16 crore in the quarter ended March 2026 as against net loss of Rs 2.91 crore during the previous quarter ended March 2025. Sales rose 37.05% to Rs 271.93 crore in the quarter ended March 2026 as against Rs 198.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 286.41% to Rs 3.98 crore in the year ended March 2026 as against Rs 1.03 crore during the previous year ended March 2025. Sales rose 50.22% to Rs 1125.54 crore in the year ended March 2026 as against Rs 749.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales271.93198.41 37 1125.54749.25 50
OPM %-0.79-1.10 -0.470.77 -
PBDT-2.15-2.17 1 5.325.81 -8
PBT-2.30-2.30 0 4.765.28 -10
NP-3.16-2.91 -9 3.981.03 286